26 May 2013
Keywords: Merck & Co, A:LK Abello, Ragweed allergy immunotherapy, USA, FDA, Milestone payment
Article | 11 March 2013
US pharma giant Merck & Co (NYSE: MRK) has submitted a Biologics License Application (BLA) to the US Food and ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
11 March 2013
24 May 2013
© 2013 thepharmaletter.com